Current treatment of multidrug resistant tuberculosis in Ethiopia: an aggregated and individual patients’ data analysis for outcome and effectiveness of the current regimens

Current treatment of multidrug resistant tuberculosis in Ethiopia: an aggregated and individual patients’ data analysis for outcome and effectiveness of the current regimens

Abstract Background The programmatic management of Multidrug-resistant tuberculosis (MDR-TB) is entirely based on a WHO recommended long-term, 18–24 month lasting treatment regimen. However, growing evidence shows that low treatment success rate and high rates of adverse events are associated with t...

Full description

Bibliographic Details
Main Authors: Setegn Eshetie, Animut Alebel, Fasil Wagnew, Demeke Geremew, Alebachew Fasil, Ulrich Sack
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Infectious Diseases
Subjects:
Ethiopia
MDR-TB
Treatment success
Online Access:http://link.springer.com/article/10.1186/s12879-018-3401-5

Internet

http://link.springer.com/article/10.1186/s12879-018-3401-5

Similar Items